(Reuters) - Investors will be squarely focused on Abbott Laboratories results on Tuesday to assess the impact of swift vaccination rollout on demand for the company's COVID-19 tests. Diagnostic test ...
In a study involving nearly 1,000 patients seen at a Baltimore field hospital during a five-month period in 2022, researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results